- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05624073
Blind Tracheal Intubation Through Supraglottic Airway Devices
Comparison of Blind Tracheal Intubation Through the Air-QTM Blocker and the LarySealTM Pro Laryngeal Mask Airways in Anesthetized Paralyzed Adult Patients Undergoing Elective Ophthalmic Operations
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11562
- Recruiting
- Department of Anesthesia, Surgical ICU, and Pain Management
-
Cairo, Egypt, 11562
- Recruiting
- Reham Ali Abdelhaleem Abdelrahman
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Eligible subjects of both sexes will be consecutively enrolled and randomly allocated to LarysealTM Pro group or Air-QTM Blocker group through an online randomization program (http://www.randomizer.org) with an allocation ratio of 1:1.
GL (n=35): Laryseal TM Pro will be used as a conduit for blind endotracheal intubation.
GA (n=35): Air-Q Blocker TM will be used as a conduit for blind endotracheal intubation.
Description
Inclusion Criteria:
- Age: 18-55 years old.
- ASA I&II.
- Both sexes.
- El-Ganzouri Airway Score < or =2
Exclusion Criteria:
- History of upper respiratory tract infections.
- History of obstructive sleep apnea (OSA) or STOP Bang-Score > 4.
- Potentially full stomach (trauma, morbid obesity BMI> 35 Kg/m2, pregnancy, history of gastric regurgitation and heart burn).
- Esophageal reflux (hiatus hernia).
- Coagulation disorders.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Air-QTM Blocker
GA (n=35): Air-Q Blocker TM will be used as a conduit for blind endotracheal intubation.
|
The LarysealTM Pro is the new generation mask for safe and effective airway management, as it could reduce the risk of aspiration by the integrated suction catheter port to allow effective removal of fluids and gastric contents.
So that, it could be a promising airway device as its symmetrical cuff and tube contoured to match the oropharyngeal anatomy for quick and easy first time insertion success.
It could be applied in both routine and advanced airway management for patients with a higher risk of a difficult airway, unexpected intubation difficulties, beside to airway control during anesthesia.
It was presented in the clinical market in: sizes 3, 4 and 5 (according to the body weight; size 3: 30-50Kg, size 4: 50-70 Kg, and size 5:70-100Kg) that can accept larger tracheal tube up to 7.5 and 8mm inner diameter respectively with maximum suction catheter size of 16 Fr.
Both devices accommodated standard conventional endotracheal tubes for intubation.
|
LarySealTM Pro Laryngeal Mask
GL (n=35): Laryseal TM Pro will be used as a conduit for blind endotracheal intubation.
|
The Air-QTM Blocker (Cookgas LLC, Mercury Medical, Clearwater, FL, USA) is a SAD that is intended for use as a primary airway seal and an aid for tracheal intubation in situations of anticipated or unanticipated difficult airways.
Its design includes a large airway tube inner diameter, a short airway tube length, and a tethered, removable standard 15mm circuit adapter.
These features enable direct insertion of larger tracheal tubes up to 7.5 and 8.5mm inner diameters for Air-Q sizes 3.5 and 4.5 respectively (according to body weight; size 3.5: 50-70Kg, size 4.5:70-100Kg).
In addition to the soft blocker channel (guide tube) that acts as a conduit for placing medical devices such as NG (Nasogastric) or Blocker tubes.
NG tubes are used to decompress and suction the stomach.
Standard NG tubes up to 18 Fr.
are suitable for all Air-Q Blocker sizes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total insertion time (seconds)
Time Frame: 200 seconds
|
Total insertion time (seconds): insertion time (seconds) of the SAD is the time needed for correct SAD placement &started when SAD touched teeth to the first recorded rectangular capnogram curve with satisfactory bilateral chest expansion + insertion time of the endotracheal tube through the SAD (seconds) is the time in seconds from insertion of the endotracheal tube blindly until capnographic confirmation.
|
200 seconds
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EH-2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiration and the Airways With Laryngeal Masks
-
Aga Khan UniversityRecruitingChild | Pediatrics | Laryngeal Masks | MinorsPakistan
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Cairo UniversityRecruitingLaryngeal Masks ComparisonEgypt
-
Tata Main HospitalCompletedLaryngeal MasksIndia
-
Region SkaneLund UniversityCompletedAdvanced ENT Surgery | Microbiological Flora in the Oropharynx and Lower AirwaysSweden
-
Asan Medical CenterCompletedUrinary Bladder Neoplasms | Laryngeal MasksKorea, Republic of
-
Chiang Mai UniversityUnknownLaryngeal Masks | Respiratory System Abnormalities | Anesthesia; Adverse EffectThailand
-
National Taiwan University HospitalUnknownBreast Neoplasms | Body Weight | Laryngeal MasksTaiwan
-
CSA Medical, Inc.WithdrawnLung Diseases, Obstructive | Airway Obstruction | Lung Disease Airways | Airway; Obstruction, With Emphysema
Clinical Trials on LarySealTM Pro
-
Cairo UniversityRecruitingLaryngeal Masks ComparisonEgypt
-
The University of Texas Medical Branch, GalvestonCompletedDiet | Protein | Skeletal MuscleUnited States
-
Cairo UniversityUnknown
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)Recruiting
-
United States Army Research Institute of Environmental...Eastern Michigan UniversityCompletedWeight Loss | Other Effects of High AltitudeUnited States
-
North Florida Foundation for Research and EducationPfizer; US Department of Veterans AffairsUnknownRheumatoid ArthritisUnited States
-
University of AarhusAarhus University Hospital; TrygFonden, Denmark; Sygekassernes Helsefond; Regional... and other collaboratorsCompletedChronic Kidney DiseasesDenmark
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaboratorsActive, not recruitingDysphagiaUnited States, Canada
-
Bolton MedicalActive, not recruitingAortic Dissection Type BUnited States
-
National Cancer Institute (NCI)RecruitingProstate CancerUnited States